Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Siderowf

Showing results (51-60 of 182) with videos related to

Pageof 19
Sort By:
Clinical Therapeutics|September 23, 2008
Optimal frequency for measuring health care resource utilization in Parkinson's disease using participant recall: the FS-TOO resource utilization substudyPatrick D Mauldin, Paulo Guimaraes, Roger L Albin, et al.
Journal of Parkinson'S Disease|April 18, 2022
Appropriateness of Applying Cerebrospinal Fluid Biomarker Cutoffs from Alzheimer's Disease to Parkinson's DiseaseSarah Weinshel, David J Irwin, Panpan Zhang, et al.
Sensors (Basel, Switzerland)|September 23, 2022
Deep Learning for Daily Monitoring of Parkinson's Disease Outside the Clinic Using Wearable SensorsRoozbeh Atri, Kevin Urban, Barbara Marebwa, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 13, 2012
Impaired olfaction and other prodromal features in the Parkinson At-Risk Syndrome StudyAndrew Siderowf, Danna Jennings, Shirley Eberly, et al.
Neurology|July 20, 2014
Naltrexone for impulse control disorders in Parkinson disease: a placebo-controlled studyKimberly Papay, Sharon X Xie, Matthew Stern, et al.
Brain and Language|June 22, 2011
The organization of narrative discourse in Lewy body spectrum disorderSharon Ash, Corey McMillan, Rachel G Gross, et al.
Brain and Language|November 22, 2011
Impairments of speech fluency in Lewy body spectrum disorderSharon Ash, Corey McMillan, Rachel G Gross, et al.
Neurology|February 27, 2023
Updated Percentiles for the University of Pennsylvania Smell Identification Test in Adults 50 Years of Age and OlderMichael C Brumm, Kerri A Pierz, David-Erick Lafontant, et al.
Movement Disorders Clinical Practice|January 4, 2025
An Open-Label Pilot Study to Examine the Safety, Tolerability and Efficacy of Deutetrabenazine in Isolated DystoniaAndres Deik, Whitley Aamodt, Christina Cadet, et al.
Brain and Language|October 4, 2011
Difficulty processing temporary syntactic ambiguities in Lewy body spectrum disorderMurray Grossman, Rachel G Gross, Peachie Moore, et al.
Pageof 19

Showing results (51-60 of 182) with videos related to

Sort By:
Pageof 19
Clinical Therapeutics|September 23, 2008
Optimal frequency for measuring health care resource utilization in Parkinson's disease using participant recall: the FS-TOO resource utilization substudyPatrick D Mauldin, Paulo Guimaraes, Roger L Albin, et al.
Journal of Parkinson'S Disease|April 18, 2022
Appropriateness of Applying Cerebrospinal Fluid Biomarker Cutoffs from Alzheimer's Disease to Parkinson's DiseaseSarah Weinshel, David J Irwin, Panpan Zhang, et al.
Sensors (Basel, Switzerland)|September 23, 2022
Deep Learning for Daily Monitoring of Parkinson's Disease Outside the Clinic Using Wearable SensorsRoozbeh Atri, Kevin Urban, Barbara Marebwa, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 13, 2012
Impaired olfaction and other prodromal features in the Parkinson At-Risk Syndrome StudyAndrew Siderowf, Danna Jennings, Shirley Eberly, et al.
Neurology|July 20, 2014
Naltrexone for impulse control disorders in Parkinson disease: a placebo-controlled studyKimberly Papay, Sharon X Xie, Matthew Stern, et al.
Brain and Language|June 22, 2011
The organization of narrative discourse in Lewy body spectrum disorderSharon Ash, Corey McMillan, Rachel G Gross, et al.
Brain and Language|November 22, 2011
Impairments of speech fluency in Lewy body spectrum disorderSharon Ash, Corey McMillan, Rachel G Gross, et al.
Neurology|February 27, 2023
Updated Percentiles for the University of Pennsylvania Smell Identification Test in Adults 50 Years of Age and OlderMichael C Brumm, Kerri A Pierz, David-Erick Lafontant, et al.
Movement Disorders Clinical Practice|January 4, 2025
An Open-Label Pilot Study to Examine the Safety, Tolerability and Efficacy of Deutetrabenazine in Isolated DystoniaAndres Deik, Whitley Aamodt, Christina Cadet, et al.
Brain and Language|October 4, 2011
Difficulty processing temporary syntactic ambiguities in Lewy body spectrum disorderMurray Grossman, Rachel G Gross, Peachie Moore, et al.
Pageof 19